tiprankstipranks
Promising Potential of Cartesian Therapeutics’ Descartes-08 Therapy Drives Buy Rating
PremiumRatingsPromising Potential of Cartesian Therapeutics’ Descartes-08 Therapy Drives Buy Rating
23d ago
Cartesian Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Cartesian Therapeutics Reports Q1 2025 Financial Results
26d ago
Buy Rating for Cartesian Therapeutics: Promising Clinical Progress and Stable Financial Outlook
Premium
Ratings
Buy Rating for Cartesian Therapeutics: Promising Clinical Progress and Stable Financial Outlook
27d ago
Cartesian Therapeutics management to meet with BTIG
PremiumThe FlyCartesian Therapeutics management to meet with BTIG
1M ago
Seven new option listings and one option delisting on April 16th
Premium
The Fly
Seven new option listings and one option delisting on April 16th
2M ago
Buy Rating Affirmed for Cartesian Therapeutics Due to Promising Phase 2b Trial Results and Strong Safety Profile
Premium
Ratings
Buy Rating Affirmed for Cartesian Therapeutics Due to Promising Phase 2b Trial Results and Strong Safety Profile
2M ago
Cartesian Therapeutics announces data from Phase 2b trial of Descartes-08
PremiumThe FlyCartesian Therapeutics announces data from Phase 2b trial of Descartes-08
2M ago
Cartesian Therapeutics announces employment inducement grants
Premium
The Fly
Cartesian Therapeutics announces employment inducement grants
2M ago
Buy Rating for Cartesian Therapeutics: Promising Advancements in Biopharmaceuticals and Strategic Clinical Progress
Premium
Ratings
Buy Rating for Cartesian Therapeutics: Promising Advancements in Biopharmaceuticals and Strategic Clinical Progress
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100